US2008182300A1PendingUtilityA1

Methods And Compositions For Transcription-Based Nucleic Acid Amplification

69
Assignee: KURN NURITHPriority: Jun 26, 2000Filed: Oct 31, 2007Published: Jul 31, 2008
Est. expiryJun 26, 2020(expired)· nominal 20-yr term from priority
Inventors:Nurith Kurn
C12Q 1/6865C12Q 1/6876
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods for isothermal exponential amplification of a target polynucleotide are disclosed. The methods employ two transcription modules, the first module providing linear amplification resulting in RNA transcripts, and a second module providing for further (generally cyclical) amplification resulting in more RNA transcripts. In one aspect, the amplification of the first module is composite primer based. In a second aspect, the amplification of the first module is based on target switching to generate a primer extension product comprising a promoter sequence. In all aspects, the RNA transcripts of the first transcription module are subjected to further amplification by creating an intermediate product comprising a double stranded promoter region from which transcription can occur. The invention further provides compositions and kits for practicing said methods, as well as methods which use the amplification results.

Claims

exact text as granted — not AI-modified
1 . A kit comprising (a) a propromoter template switch oligonucleotide (TSO), (b) a first primer, (c) a DNA dependent DNA polymerase, (d) an RNA dependent DNA polymerase, (e) an enzyme that cleaves RNA from an RNA/DNA hybrid, and (f) an RNA polymerase. 
     
     
         2 . The kit of  claim 1  further comprising a second primer. 
     
     
         3 . The kit of  claim 1  wherein the enzyme which cleaves RNA from an RNA/DNA hybrid has RNAse H activity. 
     
     
         4 . A kit comprising one or more containers comprising a first primer comprising a propromoter TSO, a first primer, an enzyme which cleaves RNA from an RNA/DNA hybrid and any two of: (a) a second primer, (b) an enzyme with DNA dependent DNA polymerase activity, (c) an enzyme with RNA dependent DNA polymerase activity, and (d) an RNA polymerase. 
     
     
         5 . The kit of  claims 1  or  4  further comprising deoxynucleoside triphosphates or ribonucleoside triphosphates. 
     
     
         6 . The kit of  claim 5  wherein a deoxynucleoside triphosphate or a ribonucleoside triphosphate is labeled. 
     
     
         7 . The kit of  claim 1  or  4  further comprising a nucleotide analog that upon incorporation into a primer extension product effects termination of nucleotide polymerization. 
     
     
         8 . The kit of  claim 7  wherein the nucleotide analog which effects termination is labeled. 
     
     
         9 . The kit of  claims 1  or  4  wherein one or more components is provided as a dry powder. 
     
     
         10 . A system for amplifying a sequence of interest, comprising: (a) a propromoter TSO; (b) a first primer; (c) an RNA-dependent DNA polymerase; (d) an enzyme that cleaves RNA from an RNA/DNA hybrid; and (e) an RNA polymerase. 
     
     
         11 . The system of  claim 10  further comprising a DNA-dependent DNA polymerase. 
     
     
         12 . The system of  claim 10 , wherein the RNA-dependent DNA polymerase and enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme. 
     
     
         13 . The system of  claim 11 , wherein the DNA-dependent DNA polymerase and the RNA-dependent DNA polymerase are the same enzyme. 
     
     
         14 . The system of  claim 11 , wherein the DNA-dependent DNA polymerase and enzyme that cleaves RNA from an RNA/DNA hybrid are the same enzyme. 
     
     
         15 . The system of  claim 11 , wherein the RNA-dependent DNA polymerase, DNA-dependent DNA polymerase and enzyme that cleaves RNA from an RNA/DNA hybrid are the same. 
     
     
         16 . The system of  claim 10  further comprising a second primer. 
     
     
         17 . The system of  claim 10  wherein the first primer comprised DNA.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.